Statement of Organization, Functions, and Delegations of Authority, 14578 [07-1486]
Download as PDF
<![CDATA[
14578
Federal Register / Vol. 72, No. 59 / Wednesday, March 28, 2007 / Notices
identifying the challenges associated
with pharmacogenomics product
development and integration into
clinical and public health practice. It
presents information and
recommendations in three major areas:
(1) Issues associated with research and
development; (2) ‘‘gatekeepers,’’ i.e.,
those who have major roles in directing
the course of pharmacogenomic
technologies; and (3) implementation of
pharmacogenomics to improve
outcomes in clinical practice.
SACGHS is requesting comments on
all aspects of the draft report and
recommendations. In particular, the
Committee would welcome feedback on
the following questions:
• Are the discussions of topics and
issues accurate and complete?
• Have any significant opportunities,
challenges, or other issues been missed?
• Does the report adequately describe
the range of perspectives on the issues
discussed in the report?
• Are the draft recommendations
specific enough?
• Are there other strategies for
addressing the issues?
• Which draft recommendations
should be of highest priority for the
Federal Government to address?
• Appendix A of the report identifies
major pharmacogenomics activities in
the public and private sector. Are there
other relevant initiatives that should be
included in the list?
Comments received by June 1, 2007,
will be considered by SACGHS in
preparing the final report. The draft
report and the public comments will be
discussed at a future SACGHS meeting.
Comments also will available for
public inspection at the Office of
Biotechnology Activities, Monday
through Friday, between the hours of 9
a.m. and 5 p.m.
Dated: March 22, 2007.
Elias A. Zerhouni,
Director, National Institutes of Health.
[FR Doc. 07–1532 Filed 3–26–07; 9:37 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
sroberts on PROD1PC70 with NOTICES
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
VerDate Aug<31>2005
17:09 Mar 27, 2007
Jkt 211001
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 72 FR 4514, dated
January 31, 2007) is amended to reflect
the Order of Succession for the Centers
for Disease Control and Prevention.
Section C–C, Order of Succession:
Delete in its entirety Section C–C,
Order of Succession, and insert the
following:
During the absence or disability of the
Director, Centers for Disease Control
and Prevention (CDC), or in the event of
a vacancy in that office, the first official
listed below who is available shall act
as Director, except that during a
planned period of absence, the Director
may specify a different order of
succession:
1. Chief Operating Officer, CDC.
2. Director, Coordinating Center for
Infectious Diseases.
3. Director, Coordinating Center for
Environmental Health and Injury
Prevention.
4. Director, Office of Workforce and
Career Development.
Dated: March 16, 2007.
William H. Gimson,
Chief Operating Officer, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 07–1486 Filed 3–27–07; 8:45 am]
BILLING CODE 4160–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Public Comment on the Proposed
Adoption of ANA Program Policies and
Procedures; Correction
Administration for Native
Americans (ANA)
ACTION: Notice.
AGENCY:
SUMMARY: Pursuant to section 814 of the
Native American Programs Act of 1974
(the Act) 42 U.S.C. 2992b–1, ANA
herein describes its proposed
interpretive rules, statements of general
policy and rules of agency procedure or
practice in relation to the Social and
Economic Development Strategies
(hereinafter referred to as SEDS), Native
Language Preservation and Maintenance
(hereinafter referred to as Native
Language), Environmental Regulatory
Enhancement (hereinafter referred to as
Environmental), Environmental
Mitigation (hereinafter referred to as
Mitigation), Improving the Well-Being
of Children—Native American Healthy
Marriage Initiative (hereinafter referred
to as Healthy Marriage) programs and
any Special Initiatives. Under the
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
statute, ANA is required to provide
members of the public an opportunity to
comment on proposed changes in
interpretive rules, statements of general
policy and rules of agency procedure or
practice and to give notice of the final
adoption of such changes at least thirty
(30) days before the changes become
effective. This Notice also provides
additional information about ANA’s
plan for administering the programs.
On July 18, 2005, ANA published a
Notice of Public Comment (NOPC) in
the Federal Register (Vol. 70, No. 136)
announcing an administrative policy
change on the number of awards an
eligible applicant could receive under
the SEDS program, Catalog of Federal
Domestic Assistance number 93.612.
This change only affected the Healthy
Marriage program. On November 21,
2006, ANA published the annual NOPC
in the Federal Register (Vol. 71, No.
224), which did not include a necessary
correction to the revised administrative
policy published on July 18, 2005. On
December 22, 2006, ANA published a
third Federal Register notice (Vol. 71,
No. 246) to clarify the revised
administrative policy published on July
18, 2005, on the number of awards an
eligible applicant could receive under
the SEDS program, Catalog of Federal
Domestic Assistance number 93.612.
ANA received three responses to the
December 22, 2006, NOPC clarification.
After review and consideration of the
comments received, ANA determined
that the administrative policy originally
published on July 18, 2005, required
clarification and revision. This Notice
clarifies the agency’s intent and
provides a definitive statement on the
number of awards an eligible applicant
can receive under the Catalog of Federal
Domestic Assistance number 93.612.
FOR FURTHER INFORMATION CONTACT:
Sheila K. Cooper, Director of Program
Operations, toll-free at (877) 922–9262.
Additional Information: The
following statement corrects previous
notices:
VI. ANA Administrative Policy Change
In the July 18, 2005, Federal Register
(Vol. 70, No. 136), ANA made an
administrative policy change that
eligible applicants applying for funding
under ANA’s healthy marriage special
initiative under Catalog of Federal
Domestic Assistance number 93.612,
would not be held to the long-standing
ANA policy: ‘‘An applicant can have
only one active Social and Economic
Development Strategies (SEDS) grant
operating at any given time.’’
On December 22, 2006, ANA
published notice that ANA was
clarifying its policy pertaining to
E:\FR\FM\28MRN1.SGM
28MRN1
]]>Agencies
[Federal Register Volume 72, Number 59 (Wednesday, March 28, 2007)]
[Notices]
[Page 14578]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-1486]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 72 FR 4514, dated January 31, 2007) is amended
to reflect the Order of Succession for the Centers for Disease Control
and Prevention.
Section C-C, Order of Succession:
Delete in its entirety Section C-C, Order of Succession, and insert
the following:
During the absence or disability of the Director, Centers for
Disease Control and Prevention (CDC), or in the event of a vacancy in
that office, the first official listed below who is available shall act
as Director, except that during a planned period of absence, the
Director may specify a different order of succession:
1. Chief Operating Officer, CDC.
2. Director, Coordinating Center for Infectious Diseases.
3. Director, Coordinating Center for Environmental Health and
Injury Prevention.
4. Director, Office of Workforce and Career Development.
Dated: March 16, 2007.
William H. Gimson,
Chief Operating Officer, Centers for Disease Control and Prevention
(CDC).
[FR Doc. 07-1486 Filed 3-27-07; 8:45 am]
BILLING CODE 4160-18-M
